Skip to main content
. 2024 Feb 7;281(3):522–531. doi: 10.1097/SLA.0000000000006231

TABLE 5.

Univariate and Multivariate Analysis of Significative Factors for Primary End Points

Univariate Multivariate
Favoring factors for technical success Unadjusted OR (95% CI) P * Adjusted OR (95% CI) P
Contained rupture at presentation 16.8 (0.117–0.671 <0.001 10.1 (3.0–33.6) <0.001
Risk factors for 30-day+in-hospital mortality
Technical failure 10.6 (0.077–0.525) 0.004
ICU>48 h 5.7 (0.081–0.382) 0.017
MAEs 24.1 (0.306–0.671) <0.001 9.4 (2.8–30.5) <0.001
Pulmonary complications 22.5 (0.239–0.676) <0.001 11.3 (3.0–41.5) <0.001
Acute kidney injury 4.3 (0.035–0.414) 0.039
Spinal cord ischemia 5.0 (0.006–457) 0.025
Bowel ischemia 10.6 (0.016–0.531) 0.002
30-d reinterventions 4.13 (0.008–0.428) 0.042
Risk factors for follow-up mortality Unadjusted Multivariate
HR (95% CI) P * HR (95% CI) P
Free rupture at presentation 6.3 (22.7–49.2) 0.012
Crawford I–III extension 5.3 (13.4–40.5) 0.021
Aneurysm diameter >80 mm 4.8 (30.1–51.9) 0.028 2.0 (1.0–3-8) 0.037
Technical Failure 23.8 (13.7–49.2) <0.001 2.6 (1.1–6.5) 0.045
MAEs 18.8 (13.5–40.0) <0.001
Pulmonary complications 31.2 (26.2–55.7) <0.001 3.0 (1.2–7.9) 0.021
Bowel ischemia 7.6 (21.3–50.6) 0.006
Any reinterventions 4.73 (13.7–40.2) 0.029

Data of exclusive statistical significant data are reported in the table together with the P value level (significant if <0.05).

*

P value based on χ2 test and Log-rank test.

P value based on logistic regression and Cox regression test.

ICU indicates intensive care unit; OR, odd ratio.